MIMasaaki Inoue

Masaaki Inoue

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Masaaki Inoue has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Toshiko Sano

    Department of Radiology, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan

    2 shared publications
  • Yasumasa Nishimura

    Department of Radiology, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan

    2 shared publications
  • Hirokazu Hasegawa

    Department of Radiology, Kinki University Nara Hospital, Nara 630-0293, Japan

    1 shared publication
  • Kazuki Ueda

    Department of Surgery, Kinki University School of Medicine, Osaka 589-8511, Japan

    1 shared publication
  • Kazuo Awai

    Department of Radiology, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan

    1 shared publication
  • Masahiro Watatani

    Department of Surgery, Kinki University School of Medicine, Osaka 589-8511, Japan

    1 shared publication

Latest Publications

  • MDCT of Hypervascular Hepatocellular Carcinomas: A Prospective Study Using Contrast Materials with Different Iodine Concentrations

    by Yukinobu Yagyu, Kazuo Awai, Masaaki Inoue, Ryosuke Watai, Toshiko Sano, Hirokazu Hasegawa, Yasumasa Nishimura

    OBJECTIVE. The objective of our study was to investigate the effect of different iodine concentrations in contrast materials on the depiction of hypervascular hepatocellular carcinomas (HCCs) by MDCT. SUBJECTS AND METHODS. This prospective study involved 100 consecutive patients with chronic liver disease, including 27 patients with hypervascular HCCs. The first 50 patients received 100 mL of iopamidol at a concentration of 370 mg I/mL (group A) and the subsequent 50, 100 mL at 300 mg I/mL (group B); in both groups, the contrast material was administered at a rate of 3.0 mL/sec. Unenhanced scanning and four-phase enhanced scanning at 25, 40, 60, and 180 sec after the start of contrast injection were performed. The enhancement of the aorta, liver, and portal vein was measured during each phase. In addition, tumor-to-liver contrast was calculated for the 27 patients with hypervascular HCCs. Of the 27 patients with hypervascular HCCs, 15 were in group A and 12 were in group B. RESULTS. During all phases, aortic enhancement was significantly greater in group A than group B (p < 0.01). Hepatic enhancement was significantly greater in group A than group B at 60 and 180 sec (both p < 0.01). There was no significant difference in hepatic enhancement between the two groups at 25 and 40 sec. Tumor-to-liver contrast was significantly greater in group A than group B during the late arterial phase (40 sec, p = 0.02), although there was no significant difference at 25, 60, and 180 sec. CONCLUSION. Contrast materials with higher iodine concentration are more effective for depicting hypervascular HCCs on MDCT during the late arterial phase.


  • Dynamic Multidetector CT of Breast Tumors: Diagnostic Features and Comparison with Conventional Techniques

    by Masaaki Inoue, Toshiko Sano, Ryousuke Watai, Ryuuichirou Ashikaga, Kazuki Ueda, Masahiro Watatani, Yasumasa Nishimura

    OBJECTIVE. We sought to analyze the features of breast tumors as revealed on dynamic multidetector CT (MDCT), to develop descriptors for these features, and to compare the performance of MDCT with the performance of other techniques used in the depiction of tumors.SUBJECTS AND METHODS. MDCT was performed in 149 women with suspected breast tumors, and 173 breast lesions were detected. These breast lesions were classified as either mass or nonmass enhancing lesions. For mass lesions, the margin, shape, and enhancement patterns were evaluated. For nonmass enhancing lesions, the distribution of enhancement and the types of time-density curve patterns were evaluated. MDCT was compared with mammography and sonography as a method of revealing breast tumors.RESULTS. Of the 173 breast lesions detected, 150 were mass lesions, 131 (87%) of which were malignant. Of the 23 nonmass enhancing lesions, 21 (91%) were malignant. The most highly predictive features for lesion malignancy were an irregular margin (100%), an i...